In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...
IASO Biotechnology has completed its acquisition of Singapore-based MediSix Therapeutics, expanding its international ce...
Ascletis Pharma has initiated two Phase I studies in the United States evaluating investigational once-monthly injectabl...
Scientists at Northwestern University have found that tissue environments surrounding persistent viral reservoirs share ...
The US Food and Drug Administration has approved Moderna’s mFlusiva seasonal influenza vaccine for adults aged 50 ...
A Phase III clinical trial has found that adding high-dose vitamin D3 to chemotherapy and bevacizumab does not improve p...
Researchers at Stony Brook Cancer Center have developed an experimental RNA-based therapy that reduced non-small cell lu...
Suzhou Ribo Life Science and its subsidiary Ribocure Pharmaceuticals have reported positive Phase IIa results for vortos...
Shanghai Ark Biopharmaceutical, or ArkBio, has completed dosing across all healthy-volunteer cohorts in an Australian Ph...
Kelun-Biotech has received approval from the Center for Drug Evaluation of China’s National Medical Products Admin...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
Minoryx Therapeutics and Neuraxpharm Group have announced that the European Medicines Agency’s (EMA) Committee for...
Devonian Health Group has received Health Canada authorisation to initiate a Phase II/III paediatric clinical trial of P...
Nektar Therapeutics has initiated the first two global registrational trials in its Phase 3 ZENITH AD programme for rezp...
Suzhou Ribo Life Science and subsidiary Ribocure Pharmaceuticals have reported positive Phase 2a data for vortosiran, an...
Alebund Pharmaceuticals has randomised and dosed the first participant in its global Phase IIb multi-regional clinical t...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
BioLineRx and Hemispherian will present preclinical data on GLIX1 at the 2026 European Society for Medical Oncology Annu...
Akeso has dosed the first patient in a Phase II clinical study evaluating AK146D1 in combination with ivonescimab for ad...
Halozyme Therapeutics has entered a global collaboration and licence agreement with Incyte to evaluate additional subcut...
Rege Nephro, a clinical-stage biotechnology startup focused on induced pluripotent stem (iPS) cell-based kidney regenera...
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a ...
A “precision guided” CAR T-cell therapy designed at Peter MacCallum Cancer Centre, Australia’s on...
Canada-based ExCellThera Inc., a global leader in blood stem cell expansion and metabolic fitness technologies and paren...
